Otsuka Holdings
4578.T
#706
Rank
โ‚น3.508 T
Marketcap
โ‚น6,670
Share price
-2.54%
Change (1 day)
65.86%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

EPS for Otsuka Holdings (4578.T)

EPS in 2026 (TTM): โ‚น307.78

According to Otsuka Holdings 's latest financial reports the company's current EPS (TTM) is โ‚น335.36. In 2025 the company made an earnings per share (EPS) of โ‚น416.96 an increase over its 2024 EPS that were of โ‚น384.30.

EPS history for Otsuka Holdings from 2009 to 2026

Annual EPS

Year EPS Change
2026 (TTM)โ‚น307.78-26.18%
2025โ‚น416.968.5%
2024โ‚น384.30153.9%
2023โ‚น151.36-15.71%
2022โ‚น179.57-6.18%
2021โ‚น191.39-24.1%
2020โ‚น252.1722.95%
2019โ‚น205.0956.13%
2018โ‚น131.36-25.11%
2017โ‚น175.4225.99%
2016โ‚น139.24-6.37%
2015โ‚น148.72
2014N/A-100%
2013โ‚น224.0618.06%
2012โ‚น189.781.01%
2011โ‚น187.8829.07%
2010โ‚น145.56-94.47%
2009โ‚น2,632